GlaxoSmithKline Consumer Healthcare Ltd records 7% growth for Q3
The company said its gross sales stood at Rs 1100 crores and recorded a growth of 7 % with PAT at Rs. 132 crores growing by 37 % for the same period and PBT at Rs 203 crores growing by 37 %.
Commenting on the results, Manoj Kumar, Managing Director, GlaxoSmithKline Consumer Healthcare Limited said, “We are happy to declare our results for the third quarter where we have been able to gain share in the HFD category. We have been able to successfully connect and engage with our consumers via sharp insight based communication to grow consumption of Horlicks. Our core differentiator remains our science and we will strengthen our focus to constantly innovate. Today our products continue to be available at affordable price points, reaching a larger consumer base across the country in both rural and urban markets.”
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
